These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 15882358)

  • 1. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
    Solomon B
    Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated immunotherapy for Alzheimer's disease.
    Solomon B
    Curr Opin Investig Drugs; 2007 Jul; 8(7):519-24. PubMed ID: 17659471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for Alzheimer's disease.
    McGeer PL; McGeer E
    Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology and immunotherapy of Alzheimer's disease.
    Weiner HL; Frenkel D
    Nat Rev Immunol; 2006 May; 6(5):404-16. PubMed ID: 16639431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perspectives in immunotherapy of Alzheimer's disease].
    Rossi G
    Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
    Beckman M
    Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.
    Schenk D
    Nat Rev Neurosci; 2002 Oct; 3(10):824-8. PubMed ID: 12360327
    [No Abstract]   [Full Text] [Related]  

  • 10. Current progress in beta-amyloid immunotherapy.
    Schenk D; Hagen M; Seubert P
    Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Alzheimer's disease: attacking amyloid-beta from the inside.
    Arbel M; Solomon B
    Trends Immunol; 2007 Dec; 28(12):511-3. PubMed ID: 17981084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
    Foster JK; Verdile G; Bates KA; Martins RN
    Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes.
    Esposito M; Luccarini I; Cicatiello V; De Falco D; Fiorentini A; Barba P; Casamenti F; Prisco A
    Mol Immunol; 2008 Feb; 45(4):1056-62. PubMed ID: 17850871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.
    DeMattos RB; Bales KR; Cummins DJ; Dodart JC; Paul SM; Holtzman DM
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8850-5. PubMed ID: 11438712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease.
    Wang CY; Finstad CL; Walfield AM; Sia C; Sokoll KK; Chang TY; Fang XD; Hung CH; Hutter-Paier B; Windisch M
    Vaccine; 2007 Apr; 25(16):3041-52. PubMed ID: 17287052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.
    Lafaye P; Achour I; England P; Duyckaerts C; Rougeon F
    Mol Immunol; 2009 Feb; 46(4):695-704. PubMed ID: 18930548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mucosal immunotherapy for alzheimer's disease with viral vectors].
    Hara H; Inoue M; Adachi K; Yonemitsu Y; Hasegawa M; Nabeshima T; Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):53-6. PubMed ID: 17515110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.